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Summary 
WT1 is a tumor suppressor gene with a key role in 
urogenital development and the pathogenesis of 
Wilms' tumor. Two alternative splice sites in the WT1 
transcript allow the gene to encode four proteins. 
These carry four KrLippel-type zinc fingers and to date 
have primarily been implicated in transcriptional con- 
trol of genes involved in growth regulation. However, 
here we demonstrate colocalization of WT1 with splic- 
ing factors in the fetal kidney and testis and in express- 
ing cell lines. Using immunoprecipitation, we show 
that two WT1 isoforms directly associate with one or 
a limited number of components in the spliceosomes 
and coiled bodies. Moreover, COS cell expression 
studies suggest that alternative splicing within the 
WT1 zinc finger region determines whether the protein 
localizes mainly with splicing factors or with DNA in 
transcription factor domains in the nucleus. We pro- 
pose that WT1 plays roles in posttranscriptional pro- 
cessing of RNA as well as in transcription. 
Introduction 
Wilms' tumor (WT) is a childhood kidney tumor, affecting 
1 out of 10,000 infants. It is perhaps the most striking 
example of how loss of developmental control processes 
can result in oncogenic transformation. WT is frequently 
associated with congenital urogenital anomalies (for re- 
cent reviews see Hastie, 1994; Bruening and Pelletier, 
1994). A tumor predisposition gene (WT1), implicated by 
mutation analysis in 10%-15% of cases, has been identi- 
fied. The predicted WT1 protein has four C-terminal Krup- 
pel-type zinc fingers and a proline/glutamine-rich transreg- 
ulatory domain (Call et al., 1990; Gessler et al., 1990). 
Both motifs are found in many transcription factors. Tumor 
mutation analysis and functional data show that WT1 is a 
tumor suppressor gene (Haber et al., 1993). 
The WT1 gene has ten exons that give rise to four protein 
tThe first two authors have contributed equally to this work. 
isoforms through alternative splicing: exon 5 encoding 17 
amino acids can be either included or excluded; likewise, 
lysine, threonine, and serine (KTS) can be either included 
or excluded between the third and fourth zinc fingers (Fig- 
ure 1A). WT1 expression is seen in tissues of mesodermal 
origin in cells that undergo a mesenchymal to epithelial 
switch, for example, in fetal kidneys and gonads (Hastie, 
1994). Immunohistochemical studies have confirmed the 
predicted nuclear localization of a "coarse speckled pat- 
tern" (Mundlos et al., 1993). Analysis of wtl-null mice re- 
veals that the gene is required for fetal survival beyond 
15 days of gestation and is essential for urogenital devel- 
opment (Kreidberg et al., 1993). 
The presence of the zinc fingers in WT1 suggested that 
its main physiological role would be as a DNA-binding pro- 
tein. The zinc fingers are closely related to those of the 
transcription factors EGR1 and Spl (Drummond et al., 
1994). The direct interaction between EGR1 protein and 
its consensus target sequence 5'-GCGGGGGCG-3' has 
been analyzed by crystallography (Pavletich and Pabo, 
1991). WT1 has been shown to bind the same sequence 
(Rauscher et al., 1990). This G-rich sequence is present 
in the promoter region of a large number of genes, some 
of which are involved in growth regulation. In transient 
transfection assays, the -KTS form of WT1 represses sev- 
eral of these promoters (Hastie, 1994). However, so far 
no clear in vivo target for transcriptional regulation by WT1 
has been documented. 
The alternative splicing between the third and fourth zinc 
fingers of WT1 is probably very important physiologically, 
since it is conserved from zebrafish to human (Hastie, 
1994; Kent, 1994). mRNAs encoding the +KTS isoforms 
are four times more prevalent than those encoding the 
-KTS forms (Haber et al., 1991). The +KTS isoforms do 
not readily bind the EGR1 consensus sequence (Rauscher 
et al., 1990). Recent studies have suggested that they bind 
a narrower range of DNA target sequences and with lower 
affinity than the -KTS forms (Bickmore et al., 1992; Drum- 
mond et al., 1994). The biological importance of the zinc 
finger region and its alternative splice site is clearly demon- 
strated by the distinct spectrum of constitutional mutations 
that lead not only to WT but also to severe urogenital ab- 
normalities in Denys-Drash syndrome (DDS) (Bruening 
and Pelletier, 1994). 
WT1 binding to DNA has been studied extensively in 
vitro, but we still know very little about the role of this 
protein in vivo. Confocal microscopy has made possible 
high resolution analysis of nuclear organization in whole 
cells. Nuclear factors have been shown to be localized 
in discrete domains, usually according to their particular 
functional association, such as DNA replication, transcrip- 
tion, or pre-mRNA splicing (for review see Spector, 1993). 
Nuclear domains containing small nuclear ribonucleopro- 
tein particles (snRNPs) involved in mRNA splicing have 
been intensively studied. Splicing occurs in spliceosomes, 
composed of five small nuclear RNAs (snRNAs) (U1, U2, 
U4/U6, and U5) complexed with numerous protein factors 
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Figure 1. Scheme of WT1 Isoforms and Detection of WT1 in Cultured 
Cells and Fetal Tissues 
(A) Diagram showing the four wild-type WT1 isoforms. 
(B) (i) Northern blot from M15 cells and nonexpressing cell lines (C2 
and 10Tl/2) probed with W1"1 and GAPDH cDNA probes. (ii) Western 
blot with nuclear extracts from M15cells and two nonexpressing cell 
lines (C2 and COS7) probed with the H2 anti-WT1 antibody. 
(C and D) WT1 (+/+) transfected COS7 cells stained with anti-WT1 
antibody C19 or as described. 
(E) M15 cells stained for WT1 (C19, green) and tubulin (red). 
(F and G) Cryosections of E15.5 mouse testis and kidney stained for 
WI-1 (C19, green/yellow) and nuclear Sm antigen (Y12, red). 
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Figure 2. WT1 Colocalization and Coimmunoprecipitation with Splic- 
ing Proteins 
(A and B) M15 cells stained for Sm antigens (Y12) and WT1 (C19) (A) 
or Spl (IC6) and WT1 (C19) (B). To the right images are merged, red 
denoting Sm antigen/Spl, green WT1, and yellow colocalization. 
(C) High magnification of kidney section through the proximal end of 
a S-shaped body, stained as in (A). 
(D) IP on nuclear extracts from M15 cells (lanes 1, 3, 5, 7, 9, and 11) 
or untransfected COS7 cells (lanes 2, 4, 6, 8, 10, and 12). Precipitating 
antibodies indicated above lanes. The presence of WT1 was analyzed 
by immunoblotting using the H2 anti-WT1 antibody as a probe. 
(for reviews see Moore et al., 1993; Lamm and Lamond, 
1993; Newman, 1994). snRNPs have a characteristic lo- 
calization in two nuclear domains in each nucleus: the 
interchromatin granules (IGs) seen as 20-60 speckles and 
the 1-5 coiled bodies (Nyman et al., 1986; Spector et al., 
1991 ; Lamond and Carmo-Fonseca, 1993). Here, we show 
that the +KTS isoforms of WT1 associate preferentially 
with these nuclear domains and that WT1 is coprecipitated 
with specific components of the splicing machinery. In 
contrast, the -KTS isoforms have a distribution that paral- 
lels that of classical transcription factors such as Spl and 
TFIIB, suggesting distinct functions for the WT1 isoforms. 
Results 
A Mesonephric Cell Line 
To be able to study the subnuclear localization of the WT1 
protein, we established a mouse rnesonephric cell line, 
M15. These cells have an epitheloid morphology and ex- 
press high amounts of WT1 mRNA and protein. Two WT1 
isoforms (with or without the 17 amino acids encoded by 
exon 5) of 52 and 54 kDa, respectively, could be detected 
at approximately equal levels (Figure 1B). 
Specificity of Immunohistochemical WT1 Detection 
COS7 cells were transfected with the four different splice 
forms of WT1, stained with a polyclonal antibody raised 
against the C-terminal 19 amino acids (C19), and analyzed 
by confocal microscopy. Only transfected cells showed a 
nuclear stain with the C19 antibody (Figure 1C). No stain 
was seen in cells transfected with a WT1 mutant form trun- 
cated at zinc finger 3 (T), lacking the C-terminal domain 
(data not shown). If the transfected COS cells were doubly 
stained with C19 and any of the four monoclonat WT1 
antibodies (WT48, H2, H7, and HC17), the same cells were 
positive and the subnuclear staining patterns were identi- 
cal (Figure 1D). 
A number of cell lines expressing endogenous WT1 (as 
determined by Northern blotting) and nonexpressing con- 
trols were stained with antibodies C19, H2, H7, or HC17. 
Expressing cell lines (M15, PYT45, and AC29) all showed 
a characteristic nuclear staining pattern, whereas nonex- 
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pressing cells (10Tl/2 and C2) were not stained. The WT1 
localization, analyzed by confocal microscopy and serial 
sections, was characterized by 20-50 distinctly stained 
irregular foci set against a diffuse nucleoplasmic back- 
ground generally excluding the nucleoli (data not shown). 
In some cases, a weak asymmetric ytoplasmic stain was 
seen immediately adjacent o the nucleus (Figure 1E). Kid- 
neys and testes from embryonic day 15.5 (E15.5) mouse 
embryos showed very characteristic staining patterns. In 
the testis, WT1 protein was localized in Sertoli cells lining 
the early seminiferous tubules (Figure 1F). In the kidney, 
strong stain was seen in the proximal end of the S-shaped 
body, corresponding to the cells giving rise to the glomeru- 
lar podocytes (Figure 1G). In both cases, this is in accor- 
dance with previous studies (Pritchard-Jones et al., 1990; 
Pelletier et al., 1991; Mundlos et al., 1993). Overlapping 
patterns were seen using C19, H2, and H7 antibodies. 
High magnification revealed subnuclear staining patterns 
very similar to those seen in WTl-expressing cell lines 
(see below). In transfected COS cells, WTl-expressing 
cell lines, fetal kidney, and testis, no C19 stain could be 
detected in the presence of excess of immunizing peptide 
(data not shown). 
WT1 Colocalizes with Splicing Factors 
In Vitro and In Vivo 
The subnuclear localization of WT1 is very similar to the 
"speckled" pattern described for splicing factors (Nyman 
et al., 1986; Spector et al., 1991). The localization of WT1 
and splicing factors was compared by staining WT1- 
expressing cells for both WT1 (C19) and Sm antigens (Y12 
antibody). The latter are motifs common to a number of 
snRNP proteins (Pettersson et al., 1984). The strong foci, 
which are most characteristic for both WT1 and snRNP 
staining, overlap perfectly. The overall staining is not iden- 
tical, owing to a larger relative contribution of the diffuse 
background stain for WT1 than for the Sm antigens (Fig- 
ure 2A). 
The colocalization between WT1 and Sm antigens was 
also studied in fetal testes and kidneys. Figure 2C shows 
a clear cotocalization between WT1 and Sm antigens in 
a section through the proximal portion of an S-shaped 
body from an E15.5 fetal kidney. 
To investigate whether the localization seen for WT1 is 
unique or can be demonstrated for other related zinc finger 
proteins, M 15 cells were stained for the transcription factor 
Spl. The Spl antibody shows a diffuse nuclear stain in the 
fluorescence microscope, but confocal analysis reveals a 
large number of small fool. These do not colocalize with 
the larger foci of WT1; on the contrary, the localization 
is better characterized as nonoverlapping (Figure 2B). A 
similar pattern for Spl was seen in fetal testis and kidney 
(data not shown). Excess of the Spl immunizing peptide 
completely abolished staining (data not shown). In immu- 
noprecipitation (IP), a single band was seen at 95 kDa 
(Briggs et al., 1986; see below). 
WT1 Is Directly Associated with Splicing Complexes 
To test whether the colocalization of WT1 and splicing 
factors could be caused by direct association between 
WT1 and splicing complexes in M15 cells, IPs were per- 
formed with a series of antibodies against proteins found 
in the spliceosomes or coiled bodies. The latter is a highly 
conserved nuclear organelle of unknown function con- 
taining snRNPs involved in splicing (Lamond and Carmo- 
Fonseca, 1993). The immunoprecipitated proteins were 
analyzed by Western blotting using the H2 antibody as 
a probe (Figure 2D). The WT1 protein was found to be 
coprecipitated with antibodies against the Sm motif (Y12), 
the 70 kDa polypeptide of the U1 snRNP complex (U1- 
70K), the B" protein of the U2 complex (U2-B"), and p80 
coilin (a protein unique to the coiled bodies). The mono- 
clonal H2 anti-WT1 antibody was used as a positive con- 
trol, and autoimmune antibodies against centromere pro- 
teins (CREST) were used as a negative control. The 
specificity of the IPs with antibodies against snRNPs (Y12, 
U1-70K, and U2-B") and with the CREST serum was 
checked by probing Western blots either with the mono- 
clonal Y12 anti-Sin antibody or with the CREST serum, 
respectively (data not shown). 
WT1 Relocalizes in the Nucleus with a Subgroup 
of Splicing Factors 
The localization of splicing factors in the nucleus has been 
demonstrated to be highly dynamic and influenced by a 
number of factors such as rate of transcription and heat 
shock. The changes in localization are to a large extent 
splice factor dependent (Spector et al., 1991; Carmo- 
Fonseca et al., 1992; O'Keefe et al., 1994). To test whether 
WT1 relocalizes with splicing factors and in an attempt o 
identify a subgroup of splicing factors with which WT1 
could interact, M15 cells were exposed to two treatments 
known to alter nuclear localization of splicing proteins. 
Disruption of Pre.mRNA Spficing 
The assembly of snRNPs on pre-mRNA requires a number 
of specific RNA-RNA interactions. Oligonucleotides that 
interfere with these interactions have been shown to inhibit 
splicing and to change the nuclear localization of splicing 
factors in a specific fashion (O'Keefe et al., 1994). To test 
whether the localization of WT1 in the nucleus depends on 
adequate assembly of the spliceosomes, M15 cells were 
injected with either of two oligonucleotides, one comple- 
mentary to the 5' end of the U1 snRNA (U1C), the other 
to nucleotides in U6 snRNA that bind U2 and U4 snRNA 
(U6C) (Pan and Prives, 1988; O'Keefe et al., 1994). Intro- 
duction of either oligonucleotide l d to rearrangement of 
Sm antigens in the nucleus, with a concentration of the 
protein in enlarged foci and a marked decrease of the 
diffuse background stain (Figure 3A). WT1 also became 
concentrated within larger foci and showed a decrease of 
the diffuse background stain, although more of the latter 
remained than for Sm antigens (Figure 3C). Two control 
oligonucleotides (C1 and C2) showed no effect (Figures 
3B and 3D). 
Actinomycin D 
Actinomycin D inhibits cellular transcription and causes 
a number of splicing factors to relocalize to large foci simi- 
lar to those seen after oligon ucleotide injections. However, 
a subgroup of splicing factors such as the U 1-70K protein, 
the U2 snRNP auxiliary factor (U2AF), and pS0 coilin are 
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Figure 3. Relocalization ofWT1 with Splicing Factors 
(A-D) M15 cells injected cytoplasmically with red fluorescent dextran d oligonucleotides U6C (complimentary to U6 snRNP) or C2 (control), and 
stained for Sm antigens or WT1. 
(E) M15 cell after 2 hr of actinomycin D, stained for Sm antigens (Y12) and WT1 (C19). 
(F and G) IP on nuclear extract from M15 cells with (lanes 2, 4, 6, 8, and 10) or without actinomycin D (lanes 1, 3, 5, 7, and 9). Precipitating 
antibodies indicated above lanes. Western analysis was performed in duplicate, ither with the anti-WT1 antibody WT48 (F) or the anti-Spl antibody 
PEP2 (G) as probes. 
known to concentrate around the remnants of the nucleoli 
(Carmo-Fonseca et al., 1991,1992). When M 15 and AC29 
cells were exposed to actinomycin D, WT1 relocalized to 
very characteristic circular structures consisting of a small 
number of linked foci. The stain was found to encircle the 
nucleolar emnants (as seen with phase microscopy; data 
not shown). The same pattern was seen with C19, H2, 
H7, and HC17 antibodies. In contrast, Sm antigen was 
mainly concentrated to multiple large foci scattered in the 
nucleoplasm. A weak staining of the perinucleolar struc- 
ture remains, suggesting that some Sm antigen may relo- 
calize with WT1 (Figure 3E). 
The pattern of IP also changed following actinomycin 
D treatment (Figure 3F). WT1 coprecipitated with snRNP 
proteins in control cells (Figure 3F, lane 5), but not after 
treatment with actinomycin D (lane 6) (similarly for U 1-70K 
and U2-B'; data not shown). However, WT1 is associated 
with a component of the coiled bodies (p80 coilin) both in 
the absence and in the presence of actinomycin D (Figure 
3F, lanes 9 and 10). WT1 was precipitated with the anti- 
WT1 antibody, before and after actinomycin D treatment 
(Figure 3F, lanes 3 and 4). Therefore, the IP data closely 
mimic the findings with immunohistochemistry, namely 
that WT1 colocalized with snRNPs under control condi- 
tions, but after actinomycin D only with one or a small 
number of splicing proteins, i.e., those found to also encir- 
cle the nucleolar emnants. Spl was only precipitated with 
the anti-Spl serum and not by any of the antibodies di- 
rected against splicing proteins (Figure 3G). WT1 was not 
precipitated by the anti-Spl serum (Figure 3F, lanes 1 
and 2). 
WT1 Loca l i za t ion  Is Sp l i ce  Form Dependent  
Since none of the WT1 antibodies used in this study are 
splice form specific and assuming that all four messages 
are translated, the nuclear localization of WT1 described 
above in vitro and in vivo must be a composite of four 
proteins. In an attempt o compare the localization of the 
four different proteins, COS7 cells were transfected with 
each of the four forms. In situ hybridization and Northern 
blotting showed that the efficiency of transfection as well 
as the expression of the vector was the same for all four 
constructs (data not shown). 
The W-I'I localization in the nucleus was scored into 
three categories: "speckled patterns" were characterized 
by strongly stained irregular foci set against a diffuse nu- 
clear background; "domains" were defined as distinct ar- 
eas of diffuse stain with little or no background; "diffuse" 
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Table 1. WT1 Nuclear Staining Pattern in WT1-Transfected COS 
Cells (Percentage of Transfected Cells) 
Nuclear Pattern 
Splice Speckles Domains Diffuse n 
(- / -)  30 46 24 287 
(+/-) 42 11 47 168 
(-/+) 62 7 31 212 
(+/+) 85 5 10 229 
stain was defined as nuclei with a general stain, in which 
neither speckles nor large domains could be clearly distin- 
guished. The analysis of approximately 200 transfected 
cells, scored blindly from three to six separate experi- 
ments, suggested differences in WT1 localization between 
the four WT1 splice forms: (-/-), (+/-), (-/+), and (+/+), 
for which + and - denote presence and absence, respec- 
tively, of the 17 amino acid insert/KTS insert (see Figure 
1A). The (- / -)  form is characterized by domains, (+/-) by 
diffuse stain, and (-/+) and (+/+) by speckled patterns 
(Table 1). The differences in splice form localization are 
independent of the method of fixation, since 4% paraform- 
aldehyde gave similar results (data not shown). 
IPs from M15 cells showed that WT1 associates with 
components of the spliceosomes and the coiled bodies 
(see Figure 2D). To evaluate whether any difference 
among the WT1 isoforms could be observed in this regard, 
transfected COS7 cells were counterstained with antibod- 
Table 2. Colocalization between WT1 and Sm Antigen in 
WT1-Transfected COS Cells (Percentage of Transfected Cells) 
-KTS +KTS n 
-17 24 69 215; 172 
+17 32 75 128; 159 
ies against Sm antigen or p80 coilin. When the localization 
of WT1 and Sm antigens were compared, a high degree 
of colocalization was found for two of the isoforms, namely 
(+/+) and (-/+) (Figures 4A and 4B). Table 2 suggests that 
the most important determinant for colocalization between 
WT1 and the Sm antigens is the presence of the KTS 
sequence. In the absence of KTS, the staining patterns 
were best described as nonoverlapping in 65% (+/-) and 
51% (-/-) of the cells (Figures 4C and 4D). For +KTS 
protein, the frequency of cells with nonoverlapping pat- 
terns was only 12% (-/+) and 9% (+/+), respectively. 
Besides the three patterns described above, some 
transfected cells showed strong WT1 stain in the immedi- 
ate vicinity of, or partially overlapping with the nucleolus 
(Figures 4E-4G). Cells doubly stained for WT1 and p80 
coilin showed colocalization to these structures, sug- 
gesting that they are coiled bodies. Besides these larger 
"paranucleolar" coiled bodies, p80 coilin antibody identi- 
fied two to five smaller loci in the nucleoplasm (Figure 
4G). WT1 speckles were found to colocalize with some 
Figure 4. Differential Localization of WT1 Isoforms and Localization of WT1 in Coiled Bodies 
COS7 cells transfected with WT1 isoforms as indicated. (A)-(E) stained for WT1 (C19) and Sm antigen (Y12). In merged images, red denotes 
WT1, green Sm antigen, and yellow colocalization. (E-G) Paranucleolar coiled bodies. WT1 antibodies were C19 (E and F) and H2 (G). 
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Figure 5. Subnuclear Localization of WT1 Isoforms Relative to Other Nuclear Proteins 
COS7 cells transfected with WT1 (A, B, C, E, and F) or PAX6 (D) and stained as indicated: WT1 (H2 in [A], [C], and [F]; C19 in [E]); Spl (PEP2). 
The color image is the left (red) and right (green) images merged, colocalization is seen as yellow. 
but not all of these. When the four isoforms of WT1 were 
compared with regard to their localization in paranucleolar 
coiled bodies, the KTS insert again was the most important 
determinant for this localization: 9% ( - / - )  versus 40% 
(-/+) and 140/o (+/-) versus 32°/o (+/+) (n = 168-226). 
Is WT1 Involved Both in Transcriptional Control 
and mRNA Processing? 
Viral infection often leads to drastic changes in the nuclear 
organization; the localization of splicing factors changes 
and large domains for replication and transcription can be 
identified (Wilcock and Lane, 1991; Bosher et al., 1992; 
Jim~nez-Garcia and Spector, 1993). COS cells are trans- 
formed with SV40 virus lacking the viral origin of replica- 
tion. Transient ransfections are carried out using a cloning 
vector that contains the SV40 origin, so that episomal repli- 
cation takes place in a process similar to that seen after 
acute SV40 infection (Gluzman, 1981). 
To interpret the subnuclear localization of the -KTS 
forms of WT1 in transfected COS cells, we set out to test 
whether the typical diffuse or domain localization could 
be associated with any functional nuclear domain in the 
transfected cells. Spl is a well-characterized transcription 
factor with a DNA-binding domain similar to that of WT1 
(Kadonaga et al., 1987; Drummond et al., 1994). SV40 
infection induces high levels of Spl expression (Saffer et 
al., 1990). Cells transfected with the four forms of WT1 
were stained for WT1 and Spl.  Nontransfected COS cells 
show a granular staining pattern for Spl similar to that of 
M 15 cells (see Figure 2B), whereas transfected cells show 
a marked increase in Spl and a drastic change in its local- 
ization. Figures 5A-5C show that overexpressed Spl lo- 
calizes in large domains in the nucleus, which are immedi- 
ately adjacent to but not overlapping with the U2-B" 
splicing factor (Figure 5B). This staining pattern was also 
seen after transfection with empty vector (containing SV40 
origin) and was independent of which WT1 construct was 
used. The Spl domains show poor colocalization with the 
(+/+) form of WT1 (Figure 5A) but colocalize perfectly with 
the ( - / - )  form (Figure 5C). Table 3 shows that the most 
important determinant for colocalization between WT1 
and Spl in transfected COS cells is the absence of the 
KTS sequence. 
To test whether the localization in domains after trans- 
fection was specific for zinc finger proteins or is also seen 
for other transcription factors, we studied PAX6, which is 
a member of a family of transcriptional regulators impli. 
cated in developmental control (Strachan and Read, 
1994). PAX6 expressed in transfected COS7 cells also 
localizes in large domains in the nucleus, and as in the 
case of Spl, very little overlap is seen between PAX6 and 
the speckles containing splicing factors (Figure 5D). Dou- 
ble staining for PAX6 and Spl shows perfect overlap (data 
not shown). In COS cells that were cotransfected with 
PAX6 and WT1, perfect colocalization was found twice as 
Association of WT1 with Splicing Complexes 
397 
Table 3. Colocalization between WT1 and Spl in WT1-Transfected 
COS Cells (Percentage of Transfected Cells) 
-KTS +KTS n 
-17 72 33 64; 40 
+17 48 9 40; 69 
frequently when the (- / - )  form of WT1 was used versus 
when the (-/+) form was used (data not shown). 
In adenovirus-infected HeLa cells, RNA polymerase II 
relocates to large domains similar to those found to contain 
WT1 (-KTS), Spl, and PAX6 in transfected COS cells 
(Jimenez-Garcia and Spector, 1993). To test whether the 
shared domains in COS cells could be transcriptional, cells 
were stained with an antibody to the basal transcription 
factor TFIIB (S1-1). in untransfected cells, TFIIB is rather 
diffusely localized in the nucleus; however, following trans- 
fection it is concentrated in the same domains as WT1 
(-KTS), PAX6, and Spl (Figure 5F). If transfected COS 
cells are treated with DNase I, domains can no longer be 
identified for Spl or for WT1 (-KTS) (data not shown), 
suggesting that this localization depends on DNA binding. 
We therefore suggest that the identified omains are areas 
in which transcription factors are concentrated. 
Factors Influencing the Subnuclear 
Localization of WT1 
Our results with transfected COS cells suggest that the 
presence of the KTS insert between zinc fingers 3 and 
4 shifts the protein localization from transcription factor 
domains to sites where splicing factors are concentrated. 
To test this hypothesis further, we transfected COS cells 
with ( - / - )  and (+/+) forms of WT1. After fixation, the cells 
were treated with RNase A or DNase I. In (+/+) transfected 
cells, RNase A treatment decreased the frequency of nu- 
clei with WT1 in speckles to 20% (n = 35) (controls 85%; 
Table 1), whereas in ( - / - )  cells the value was unchanged 
from control (27% [n = 37] versus 30%; Table 1). Instead 
of localizing in speckles, the (+/+) protein was seen in 
domains or diffusely in the nucleoplasm (66% and 14%, 
respectively). Of these RNase A-treated cells, 68% showed 
good colocalization with Spl in domains, but these could 
not be seen if the cells were treated with both RNase A 
and DNase I, again suggesting that this localization is de- 
pendent on DNA binding. 
As stated above, when ( - / - )  transfected cells were 
treated with DNase I, the typical domains could no longer 
be seen. Spl was undetectable, suggesting that this pro- 
tein cannot remain in a cell devoid of DNA. WT1, on the 
other hand, did remain in DNase I-treated nuclei, but lo- 
calizing in speckles (86%, n = 65) and colocalizing with 
Sm antigens (69%, n = 35). DNase I treatment does not 
change the localization of (+/+) protein, and 89% of the 
cells show good colocalization between WT1 and Sm anti- 
gens (n = 35). 
The importance of the zinc fingers for WT1 localization in 
splicing domains was evaluated by analyzing two mutant 
WT1 proteins with zinc finger alterations: one point muta- 
tion in zinc finger 3 common in DDS patients, Arg-394 to 
Trp in the (-/+) form (D), and the other a terminal deletion 
from the middle of zinc finger 3 (T) (Bruening and Pelletier, 
1994). When expressed in COS cells, both proteins show 
localization to nuclear speckles (81% [n = 194] and 97% 
[n = 35]) and both colocalize very poorly with Spl (3% 
[n = 40] and 4% [n = 27] colocalization). If anything, the 
mutant forms of WT1 localize better with splicing factors 
than the wild-type +KTS forms, 93% of D-transfected cells 
show very good colocalization between WT1 and Sm anti- 
gens (n -- 154) (Figure 5E). It is therefore highly unlikely 
that zinc fingers 3 and 4 are directly involved in localizing 
the +KTS forms to splicing complexes. Likewise, Table 2 
suggests that exon 5 (i.e., the 17 amino acid alternative 
insert) plays no role in localization to splicing complexes. 
Discussion 
This study shows that the tumor suppressor gene product 
WT1 associates with components of the cellular splicing 
machinery in vivo. WT1 and splicing factors colocalize in 
the two major nuclear domains known to contain snRNPs: 
speckles and coiled bodies. The subnuclear localization 
of WT1 is dynamic. Disruption of pre-mRNA splicing and 
actinomycin D treatment, which are known to relocalize 
splicing factors, also change WT1 localization similarly. 
WT1 is coimmunoprecipitated by monoclonal antibodies 
against a number of well-defined splicing factors, sug- 
gesting that it is interacting directly with components of 
the splicing machinery. In transfected COS cells, the asso- 
ciation is most typically seen with the most abundant forms 
of WT1 (+KTS), whereas the -KTS forms are shown to 
associate mainly with DNA in transcription factor domains. 
Model for the Differential Subnuclear Localization 
of WT1 Isoforms 
The conclusion that the alternatively spliced forms of WT1 
(+KTS and -KTS) localize differentially to speckles/coiled 
bodies and transcription factor domains is based on exper- 
iments with transfected COS cells. We believe it reason- 
able to conclude that WT1 localization in the COS cells 
will reflect its localization and function in endogenously 
expressing cells for the following reasons. WT1 localiza- 
tion in large transcription factor domains fits previous data 
demonstrating DNA binding (Bickmore et al., 1992; Rup- 
precht et al., 1994; Drummond et al., 1994). Colocalization 
with splicing factors is seen in fetal tissues, M15 kidney 
cells, and COS cells (Figures 2 and 4). Furthermore, the 
sum of the patterns observed in COS cells expressing the 
four different WT1 isoforms more or less approximates 
the pattern observed in M15 cells (allowing for the antici- 
pated excess of +KTS over -KTS forms; Figure 1E versus 
Figures 4A-4D). 
We must emphasize that the difference in localization 
between the +KTS and -KTS forms of WT1, though dra- 
matic, is not absolute (Tables 1-3). This is also underlined 
by the experiment in which COS cells transfected with the 
(+/+) form were treated with RNase; this resulted in the 
localization of most WT1 molecules to transcription factor 
domains. Conversely, when COS cells transfected with 
Cell 
398 
the ( - / - )  form of WT1 were treated with DNase, the protein 
was found to associate with splicing factors in a high pro- 
portion of cells. We believe that this represents, in part, 
relocalization of WT1. In a similar vein, two proteins with 
zinc finger mutations howed a heightened colocalization 
with splice factors. Clearly, the domain(s) required for in- 
teraction with splice complexes is present in all four WT1 
isoforms. 
Given all these considerations, why do the +KTS and 
-KTS forms of WT1 take up (predominantly) different Io- 
calizations in the nucleus? The model we propose can be 
summarized as follows: the -KTS forms of WT1 primarily 
bind DNA, because of broad target site specificity, high 
DNA affinity, or both. The proteins are able to associate 
with splicing complexes and will do so if the DNA targets 
are unavailable. The +KTS forms of WT1, on the other 
hand, will primarily associate with splicing factors, be- 
cause of a limited number of DNA target sites, low DNA 
affinity, or both (Bickmore et al., 1992; Drummond et al., 
1994). 
What Is the Nature of the Interaction of WT1 
with Splicing Complexes? 
WT1 appears to be a stably associated component of both 
speckles and coiled bodies, neither of which appear to 
contain DNA (Spector et al., 1991 ; Spector, 1993; Lamond 
and Carmo-Fonseca, 1993). As deletion of the last two 
zinc fingers does not appear to disrupt colocalization of 
WT1 with splice factor complexes, it is unlikely that nucleic 
acid binding (DNA or RNA) is important for the association. 
WT1 has no obvious domains characteristic for splicing 
factors such as RNP or RS motifs (Zahler et al., 1992; 
Burd and Dreyfuss, 1994). Other possible regions of inter- 
action are under investigation. 
Which splicing factors are likely candidates for interac- 
tion with WTI? It is unlikely that WTt directly interacts 
with all the proteins that contain the motifs that the immu- 
noprecipitating antibodies are known to identify specifi- 
cally (Figure 2D). The IPs were performed at intermediate 
ionic strength, and gel electrophoresis of the immunopre- 
cipitated proteins showed 10-15 bands, suggesting that 
relatively large RNP complexes were precipitated (data 
not shown) (Behrens and LOhrmann, 1991). After disrup- 
tion of the splicing machinery in M15 cells by oligonucleo- 
tide injection, WT1 relocalized in the nucleus in a similar 
fashion to the snRNPs (Figures 3A and 3C). In contrast, 
when transcription was inhibited by actinomycin D, WT1 
and most of the Sm antigens went separate ways, WT1 
showing a localization similar to p80 coilin, U1-70K, and 
U2AF (Figure 3E). After actinomycin D treatment, only an- 
tibodies against p80 coilin immunoprecipitated WT1 (Fig- 
ure 3F). Although a direct interaction between WT1 and 
p80 coilin could be envisaged, this is unlikely to be the 
whole answer, since WT1 in control cells is found in far 
more nuclear speckles than the few associated with coiled 
bodies. U2AF is found in both coiled bodies and splicing 
complexes and could be the common denominator (La- 
mond and Carmo-Fonseca, 1993). U2AF would be a highly 
interesting candidate for interaction with WT1, since it has 
been implicated in control of alternative splicing (Wu and 
Maniatis, 1993). 
RNA Processing, a Role for WT1 in Development 
and Oncogenesis? 
Since the major isoforms of WT1 (+KTS) are associated 
with splicing factors, it seems likely that they have a role 
in RNA metabolism. WT1 may be involved in mRNA trans- 
port or stability, or it may directly influence splicing. 
The functional significance of the speckles (IGs) and 
coiled bodies remains unclear. Although it now seems that 
the splicing of most transcripts occurs cotranscriptionally, 
some specific transcripts are posttranscriptionally spliced 
in close proximity to the IGs (Mattaj, 1994). It has been 
proposed that the IGs are sites of splice factor storage, 
preassembly, or both. Given the close association of WT1 
with splicing factors in IGs and coiled bodies, we think it 
is reasonable to assume that WT1 will also be associated 
with active splice complexes wherever they are located. 
Given the recent finding that splicing occurs cotranscrip- 
tionally, it should be noted that we cannot distinguish 
whether WT1 located in transcription factor domains is 
involved in transcription, splicing, or both. For these rea- 
sons, we cannot yet draw conclusions about the respective 
functions of the +KTS/-KTS forms of WTI. However, our 
findings raise the intriguing possibility that WT1 may play 
an important role in linking transcriptional control and RNA 
processing/splicing. 
It is not unprecedented that zinc finger proteins have 
functions other than DNA binding and transcriptional con- 
trol. The most carefully studied example so far is TFIIIA. 
Its nine zinc fingers are involved in transcriptional activa- 
tion of the 5S RNA promoter, but also bind specifically to 
the 5S RNA (Clemens et al., 1993). However, in contrast 
with WT1, one molecule carries out both functions and 
alternative splicing of the zinc finger domain is not involved. 
A number of transcription factors have alternatively spliced 
zinc finger domains (for review see Drummond et al., 
1994). However, it is novel that such alternative splicing 
may completely change the functional role of a protein as 
may be the case for WTI. 
All forms of WT1 have recently been shown to bind RNA 
via the zinc fingers with high affinity and sequence speci- 
ficity (A. Caricasole and A. Ward, personal communica- 
tion). Although the localization of WT1 to the splicing com- 
plexes appears to be independent of the zinc fingers, they 
could still play a very important role in the function of WT1 
once it has moved to the splicing domains, for instance 
by associating with specific mRNA species. 
It is interesting to consider the molecular pathology of 
the DDS in the light of these new findings (Hastie, 1994; 
Bruening and Pelletier, 1994). Children with DDS have 
severe abnormalities of the kidneys and gonads and are 
strongly predisposed to developing Wilms' tumors. DDS 
arises through constitutional heterozygous mutations of 
the WT1 gene, all of which affect the zinc finger region 
of the protein directly. The majority of the mutations are 
missense or nonsense mutations that alter or delete resi- 
Association of WT1 with Splicing Complexes 
399 
dues critical for DNA binding so that the protein is unable 
to bind to a range of WT1 DNA targets. Our experiments 
showed that a high proportion of such forms colocalize 
with splicing factors. A second class of particularly inter- 
esting DDS mutations affects a critical splice site essential 
for the production of the +KTS form of the molecule. From 
the studies described here, we wouBd predict that in these 
DDS patients with a reduced +KTS/ -KTS ratio a higher 
proportion of WT1 would now be able to bind DNA and a 
reduced proportion would be able to interact with splice 
factors. 
WT1 is a classic tumor suppressor gene. The prevailing 
view has it that WTI mutations cause derepression of a 
number of genes expressing growth factors or growth fac- 
tor receptors (Hastie, 1994), allowing uncontrolled growth 
of the tumor. The present data suggest that the role of 
WT1 may be more complex and that mRNA processing 
may play an important role in WT pathogenesis. Although 
WT1 is an example of a tumor suppressor gene product 
directly associated with splicing factors, it was recently 
demonstrated that the retinoblastoma protein (p110 RB) 
binds a nuclear matrix protein that colocalizes with speck- 
les (Durfee et al., 1994). 
Regulation of splicing is of fundamental importance in 
gone expression (for reviews see Horowitz and Krainer, 
1994; Parkhurst and Meneely, 1994). Our studies indicate 
that developmental processes regulated byWT1 may pro- 
vide an excellent model for studying the regulation of splic- 
ing during mammalian development. Furthermore, we can 
conclude that posttranscriptional regulation may be a key 
event in kidney and gonad morphogenesis. 
Experimental Procedures 
Cell Cultures 
The WTl-expressing mesonephric ell line M15 was established from 
mice transgenically expressing the large T protein of polyoma virus 
under control of the early viral enhancer (Rassoulzadegan et al., 1993). 
Heterozygous carriers of the transgene on the C57BL/6 x DBA/2 F1 
genetic background were mated, and embryos were retrieved 10.5 
dpc. Mesonephros was dissected as described (Hogan et al., 1986), 
and the cells dissociated (0.25% trypsin and 0.02% EDTA in PBS). 
Cells were seeded (105 per 35 mm plate) in Dulbecco modified Eagle's 
medium (DMEM, Flow Labs) with 10% fetal calf serum (FCS, GIBCO). 
Besides M15 cells, two WTl-expressing cell lines were used: PYT45 
(mouse Sertoli cells [Rassoulzadegan et al., 1993]) and AC29 (mouse 
mesothelioma cells [Davis et al., 1992]). Three nonexpressing lines 
were used: C2 (mouse myoblast), 10Tl/2 (mouse fibroblast), and 
COS7. Cells were cultured in RPMI (AC29) (GIBCO) or DMEM (all 
other cell lines) with 10% FCS, in 2- or 8-well slides (Chamber Slides) 
or in plastic flasks (Nunc) (IPs). M15 cells were cultured at 32°C with 
7.5% CO2, the rest at 37°C, all with 5% CO2 in air. 
Transfections 
The pRC/CMV vector containing CMV promoter and SV40 replication 
origin was used (Invitrogen) to express wild-type or mutant isoforms 
of mouse WT1 and the major splice form of human PAX6 (-exon 
5a). COS7 cells were transfected with electroporation (1200 V, 25 ~F) 
(Gone Pulser, Bio-Rad) and analyzed after 40-48 hr. Empty vector or 
WT1 in reverse orientation was used for controls. 
Antibodies 
Antibodies against the following antigens were used in this study. 
WT1 
C19 (Santa Cruz Biotechnology), H2, H7, HC17 (recognizing different 
epitopes in the N-terminal 181 amino acids of WT1 ; J. F. Morris and 
F. J. Rauscher III, personal communication), and WT48 (Bickmore t 
al., 1992). 
Splicing Factors 
Sm/Y12, U1-70K, U2-B', and p80 coilin (provided by A. I. Lamond), 
PAX6 
M860 (D. Engetkamp, unpublished ata). 
Centromere 
CREST/CP (provided by P. Jeppesen). 
Spl 
IC6 and PEP2 (Santa Cruz Biotechnology) 
TFIIB 
S1-1 (Santa Cruz Biotechnology) 
Tubulin 
~-Tubulin (Sigma) 
Immunohistochemistry 
Fetal kidneys and testes were isolated from Swiss mice at 13.5-15.5 
dpc and immediately frozen in liquid N2. Cryosections (10-14 p~m) 
(Jung CM3000, Leica) were placed on Tespa-coated slides, briefly 
fixed in acetone:methanol (1:1, -20°C, 5-10 min), rehydrated in PBS 
with 0.02% sodium azide (Sigma) (4°C), and immediately stained for 
immunohistochemistry (below). Cultured cells were rinsed in PBS 
(4°C), fixed as above, rehydrated, and refrigerated until stained (<1 
week). 
For staining, cells and sections were preincubated for 45 min in 
blocking solution (2°/o BSA [Sigma], 0.1% sodium azide, 0.2% Tween 
20 [ICN Biochemicals], 6.7% glycerol), incubated with primary antibod- 
ies for 1 hr at room temperature, and rinsed. Secondary antibodies 
conjugated with FITC or Texas red were used against mouse, rabbit, 
and human IgG (Sigma, Vector, and Jackson Immunoresearch Labora- 
tories). After 30 min at room temperature, cells were rinsed and 
mounted (nonfluorescent glycerine [Merck]:PBS [1:1] with 2.5% anti- 
fading agent 1,4-diazabicyclo-(2.2.2)octane [Sigma]). Antibodies were 
diluted in blocking solution, and the cells were rinsed in PBS with 
0.2% Tween. 
Confocal Microscopy 
Nuclear localization of antigens was analyzed with an Orholux II micro- 
scope (Leitz) equipped for confocal microscopy (MRC 600, Bio-Rad). 
Labeled cells were excited with an argon laser, and standard filters 
were used for simultaneous detection of FITC and Texas red. The 
staining patterns were scored as colocalizing, intermediate, or non- 
overlapping. Throughout he study, the sensitivity of the system was 
set to prevent any contribution of signal between the channels and to 
allow very thin optical sections. Other control experiments excluded 
unspecific binding of secondary antibodies. 
Northern Blotting 
Total RNA was prepared from cells by guanidium thiocyanate-phenol- 
chloroform extraction (Chomczynski and Sacchi, 1987). Of each sam- 
ple, 15 I~g was electrophoresed through a 1% agarose denaturing el 
(formaldehyde) and blotted onto a nylon filter (Hybond N, Amersham). 
Hybridization with random-primed radiolabeled probes was performed 
using standard methods (Sambrook et al., 1989). 
IP and Western Blotting 
Nuclei from M15 cells were isolated (Wijnhoids et al., 1988), resus- 
pended in ice-cold buffer A (300 mM sucrose, 60 mM KCI, 15 mM 
NaCI, 60 mM Tris-HCL [pH 8], 0.5 m M spermidine, 0.15 mM spermine, 
2 mM EDTA, protease inhibitor cocktail [Boehringer Mannheim]), and 
lysed by L-lauryl sarcosyl (2%). The DNA was sheared, and the nuclear 
lysate was cleared with protein A-Sepharose beads (Sigma) for 60 rain 
at 4°C. For IP, antibodies were directly coupled to protein A-Sepharose 
beads (Harlow and Lane, 1988). IP was performed with protein A-Sepha- 
rose antibodies in IPB100 (100 mM NaCI, 10 mM Tris-HCI, 1 mM 
EDTA [pH 8]) overnight at 4°C and washed in 50x vol for 10 min: 
once with TE (10 mM Tris-HCI, 1 mM EDTA [pH 8]), three times with 
IPB100, and three times with RIPA buffer (150 mM NaCI, 1% Nonidet 
P-40, 0.5% Na-deoxycholate, 0.1% SDS, 50 mM Tris-HCI [pH 8]). 
Immunoprecipitated proteins were eluted with 4% L-lauryl sarcosyl 
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for 60 min at room temperature and analyzed by Western blotting. 
The proteins in loading buffer (20/0 SDS, 10O/o glycerol, 60 mM Tris- 
HCL, 100 mM DTT, 0.001O/o bromophenol blue JpH 8.3]) were boiled 
for 5 rain, separated by SDS-PAGE (10% polyacrylamide), and blotted 
onto nitrocellulose (Hybond ECL, Amersham). The filter was blocked 
for 60 rain with 10/0 blocking reagent (Boehringer Mannheim) in TBS-T 
(150 mM NaCI, 20 mM Tris-HCI, 0.1O/o Tween 20 [pH 7.6]) and incu- 
bated with the primary antibody overnight at 4°C. It was then washed, 
incubated with the secondary antibody (goat anti-mouse or goat anti- 
rabbit, HRP conjugated [Sigma]) for 60 min at room temperature, and 
washed. Antibodies were diluted 1:5,000 to 1:15,000 in 0.5% blocking 
reagent in TBS-T, and filters were washed in TBS-T. Detection was 
performed by enhanced chemiluminescence (ECL, Amersham). Hyp- 
erfilm ECL films were exposed for 2-60 min. 
Manipulations of WT1 Localization 
Cell Injections 
Four oligonucleotides for injections were synthesized in house (PCR- 
Mate, Applied Biosystems): U1C, complementary to nucleotides 1-20 
of the U1 snRNA; U6C, complementary to nucleotides 49-72 of U6 
snRNA; two control oligonucleotides, C1 (Pan and Prives, 1988; 
O'Keefe et al., 1994) and C2 (5'-GACGTAAGCCGTGTGGAG-3'). 
The injection solutions contained oligonucleotides at 150 I~M and 
Texas red-conjugated extran at 7 mg/ml (lysine fixable, 70 kDa, Mo- 
lecular Probes) in 70 mM KCI, 10 mM NaH2PO4 (pH 7.2) (O'Keefe et 
al., 1994). The injection solution was filtered (Spin-X, 0.22 p_m, Costar) 
and injected into the cytoplasm of subconfluent M15 cells using Fem- 
totips microinjection eedles (Eppendorf) and an Eppendorf Microin- 
jector 5242 mounted on an Axiovert 10 inverted microscope (Zeiss). 
After injection, the culture medium was changed and the slide returned 
to an incubator for 2 hr before fixation. Cells were stained for Sm 
antigen (Y12 antibody) or WT1 (H2 or H7 antibodies), in both cases 
an FITC-conjugated secondary antibody was used. Texas red-labeled 
dextran served to identify the injected cells during the analysis. 
Actinomycin D 
To investigate how WT1 localization was changed by the transcrip- 
tional inhibitor actinomycin D, cells were exposed for 2 hr (5 I~g/ml, 
Sigma) and then fixed as above. 
RNase A and DNase I Treatment 
COS cells were cultured, transfected, and fixed as described above. 
After rehydration, the cells were incubated in either RNase-free DNase 
I (400 U/ml, Boehringer Mannheim), in RNase A (200 mg/ml, Boeh- 
ringer Mannheim), or in a combination of the two. Incubations were 
performed in PBS (with 3 mM MgCI2, 0.4% Tween 20) for 2 hr at room 
temperature. The efficiency of respective treatment was verified by 
the loss of DAPI stain after DNase I and a marked loss of Sm antigen 
after RNase A. 
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